Patents by Inventor Martin Pearce

Martin Pearce has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SMALL MOLECULE BCL-2 FUNCTIONAL CONVERTERS AS CANCER THERAPEUTICS
    Publication number: 20230129487
    Abstract: Methods for inducing growth inhibition or apoptosis of Bcl-2-expressing cells and treatments of Bcl-2 expressing cancers are provided. Additionally, assays for agents that can induce apoptosis of Bcl-2 expressing cells are disclosed.
    Type: Application
    Filed: August 19, 2022
    Publication date: April 27, 2023
    Applicant: Oregon State University
    Inventors: Siva K. Kolluri, Prasad R. Kopparapu, Martin Pearce
  • Small molecule BCL-2 functional converters as cancer therapeutics
    Patent number: 11419843
    Abstract: Methods for inducing growth inhibition or apoptosis of Bcl-2-expressing cells and treatments of Bcl-2 expressing cancers are provided. Additionally, assays for agents that can induce apoptosis of Bcl-2 expressing cells are disclosed.
    Type: Grant
    Filed: December 1, 2017
    Date of Patent: August 23, 2022
    Assignee: Oregon State University
    Inventors: Siva K. Kolluri, Prasad R. Kopparapu, Martin Pearce
  • SMALL MOLECULE BCL-2 FUNCTIONAL CONVERTERS AS CANCER THERAPEUTICS
    Publication number: 20190336469
    Abstract: Methods for inducing growth inhibition or apoptosis of Bcl-2-expressing cells and treatments of Bcl-2 expressing cancers are provided. Additionally, assays for agents that can induce apoptosis of Bcl-2 expressing cells are disclosed.
    Type: Application
    Filed: December 1, 2017
    Publication date: November 7, 2019
    Applicant: Oregon State University
    Inventors: Siva K. Kolluri, Prasad R. Kopparapu, Martin Pearce